ABBV vs MRK
By Alex · Tickerpine
AbbVie Inc. vs Merck & Co., Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | MRK |
|---|---|---|
| Price | $253.35 | $128.66 |
| Market cap | $447.62B | $317.77B |
| P/E ratio | 123.6 | 36.2 |
| ROE | — | 18.94% |
| Profit margin | 5.79% | 13.59% |
| Revenue growth | 12.40% | 4.90% |
| Dividend yield | 2.73% | 2.64% |
| Beta | 0.31 | 0.22 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs MRK in plain English
- ABBV is the bigger company — about 1.4× the market cap of MRK.
- MRK is cheaper on earnings (P/E 36.2 vs 123.6).
- ABBV is growing revenue faster (12% vs 5%).
- ABBV has the higher dividend yield (2.73% vs 2.64%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.